⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IRD News
Opus Genetics, Inc. Common Stock
Opus Genetics to Host Virtual R&D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts
globenewswire.com
IRD
Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
IRD
Opus Genetics to Present at the 2026 Jefferies Global Healthcare Conference
globenewswire.com
IRD
Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference
globenewswire.com
IRD
Form 8-K
sec.gov
IRD
Opus Genetics Announces Financial Results for First Quarter 2026 and Provides Corporate Update
globenewswire.com
IRD
Opus Genetics Presents Clinical and Preclinical Data at ARVO 2026 Demonstrating Continued Pipeline Advancement in Inherited Retinal Diseases
globenewswire.com
IRD
Opus Genetics Completes Enrollment in Cohort 1 of Phase 1/2 OPGx-BEST1 Gene Therapy Study
globenewswire.com
IRD
Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program
globenewswire.com
IRD
Opus Genetics to Participate in Leading Medical Conferences in May 2026
globenewswire.com
IRD